Sponsor · clinical trials

Hospital de Clinicas de Porto Alegre clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Brazil register with Hospital de Clinicas de Porto Alegre as lead sponsor. Synced 14 Nov 2026

50Current trials

26Recruiting now

15Drugs in these trials

1Trial register

Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany

Compiled from ClinicalTrials.gov and CTIS registry records · Synced 14 Nov 2026 · Editorial standards

At a glance

Hospital de Clinicas de Porto Alegre is the lead sponsor of 50 current clinical trials in our Brazil register. 26 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Dapagliflozin, Cefuroxime and Dapagliflozin Tab. The most-studied condition is Heart Failure.

ClinicalTrials.gov trials by status

Recruiting2652%
Not yet open1632%
Active, closed36%
By invitation510%

Trials by phase

Not applicable3060%
Observational510%
Phase 448%
Phase 236%
Phase 2/336%
Phase 324%
Phase 124%
Phase 1/212%

Clinical trials sponsored by Hospital de Clinicas de Porto Alegre

50 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
Evaluation of the Efficacy of 0.08% Tacrolimus Nanoencapsulated Aqueous Solution Spray Vs. 0.1% Free Tacrolimus Commercial Ointment in the Treatment of Oral Lichen Planus NCT06591884 · ClinicalTrials.gov ↗ · Oral Erosive Lichen Planus Drug: Tacrolimus	Phase 1/2	Recruiting	2024-09	Brazil
Medication Withdrawal in Stable HF With Improved LVEF NCT07489547 · ClinicalTrials.gov ↗ · Heart Failure	Phase 2/3	Recruiting	2025-03	Brazil
Quality of Life Questionnaire in Pulmonary Hypertension EMPHASIS-10: Brazilian Adaptation and Validation NCT07822997 · ClinicalTrials.gov ↗ · Pulmonary Hypertension, Quality of Life	Observational	Recruiting	2026-03	Brazil
Tracheal Cuff Pressure and Postoperative Complications NCT07264179 · ClinicalTrials.gov ↗ · Tracheal Intubation, Postoperative Complications (Cardiopulmonary)	Observational	Recruiting	2026-01	Brazil
Use of Letrozole for Ectopic Pregnancy NCT06354439 · ClinicalTrials.gov ↗ · Ectopic Pregnancy Drugs: Letrozole, Methotrexate, Methotrexate Sodium	Phase 4	Recruiting	2024-03	Brazil
The Impact of Geriatric Assessment on the Treatment Plan of Elderly Patients With T2DM NCT06469437 · ClinicalTrials.gov ↗ · Type2diabetes, Frail Elderly Syndrome, Frailty	Not applicable	Recruiting	2024-07	Brazil
Clinical Trial Comparing Oral Versus Intravenous Cefuroxime in Pregnant Women with Pyelonephritis NCT06527560 · ClinicalTrials.gov ↗ · Pyelonephritis in Pregnancy Drug: Cefuroxime	Phase 4	Recruiting	2024-09	Brazil
Effects of HIIT VR Exergame on Attention and Executive Function in Young People With ADHD NCT06632249 · ClinicalTrials.gov ↗ · Attention Deficit Hyperactivity Disorder	Not applicable	Recruiting	2024-09	Brazil
Nutritional Intervention for Constipation Symptoms in Patients With Parkinson's Disease NCT07213856 · ClinicalTrials.gov ↗ · Parkinsons Disease (PD), Constipation - Functional	Not applicable	Recruiting	2026-04	Brazil
Cardio-Oncology Rehabilitation in Breast Cancer Patients Undergoing Chemotherapy NCT07823660 · ClinicalTrials.gov ↗ · Breast Cancer	Not applicable	Recruiting	2025-12	Brazil
Suprapapillary Metal Stent vs. Routine Transpapillary Drainage in Malignant Hilar Biliary Obstruction (SMART-B Trial) NCT07558304 · ClinicalTrials.gov ↗ · Cholangiocarcinoma, Bile Duct Neoplasms, Malignant Biliary Obstruction	Not applicable	Recruiting	2026-06	Brazil
Methylphenidate in Adults With Attention Deficit/Hyperactivity Disorder NCT02951754 · ClinicalTrials.gov ↗ · Attention Deficit Disorder With Hyperactivity Drug: Methylphenidate	Phase 4	Recruiting	2002-02	Brazil
Pelvic Floor Physical Therapy and Exercise for Women With Endometriosis and Chronic Pelvic Pain NCT07733583 · ClinicalTrials.gov ↗ · Endometriosis, Chronic Pelvic Pain	Not applicable	Recruiting	2026-03	Brazil
Effect of Partial Dietary Replacement From Animal to Plant-Based Protein for Type 2 Diabetes Management NCT05706155 · ClinicalTrials.gov ↗ · Type 2 Diabetes, Overweight, Obesity	Not applicable	Recruiting	2022-11	Brazil
Effect of Nutrition Education Groups in the Treatment of Patients with Type 2 Diabetes NCT05598203 · Diabetes Mellitus, Type 2	Not applicable	Recruiting	2022-09	Brazil
From Prevention to Treatment: How Biological Rhythms Can Maintain Perinatal Mental Health NCT06246214 · ClinicalTrials.gov ↗ · Depression, Postpartum, Anxiety State	Not applicable	Recruiting	2024-01	Brazil
IPT-based Group Intervention by Non-specialist for Improvement of Depressive Symptoms in Community Young Adults in Brazil NCT06480019 · ClinicalTrials.gov ↗ · Depression, Interpersonal Relations	Not applicable	Recruiting	2024-03	Brazil
Cell Therapy Associated With Endobronchial Valve NCT04018729 · ClinicalTrials.gov ↗ · Chronic Obstructive Pulmonary Disease Severe	Phase 2/3	Recruiting	2019-11	Brazil
Artificial Intelligence for Diagnosing Diabetic Retinopathy in Primary Care NCT07236879 · ClinicalTrials.gov ↗ · Diabetic Retinopathy	Not applicable	Recruiting	2024-08	Brazil
Efficacy of Artificial Intelligence for Gatekeeping in Referrals to Specialized Care NCT07019116 · ClinicalTrials.gov ↗ · Primary Care, Primary Care Patients With Chronic Conditions	Not applicable	Recruiting	2025-11	Brazil
Home-based Transcranial Direct Current Stimulation (tDCS) Compared to Duloxetine: Non-inferiority Clinical Trial (FIBROSTIM) NCT07203339 · ClinicalTrials.gov ↗ · Fibromyalgia (FM), tDCS, Duloxetine Drug: Duloxetine	Not applicable	Recruiting	2025-09	Brazil
Impact of BioFire FilmArray Pneumonia Panel vs Routine Diagnostics on Antimicrobial Outcomes (DOOR-MAT) NCT07585604 · ClinicalTrials.gov ↗ · Pneumonia - Bacterial	Not applicable	Recruiting	2026-05	Brazil
Social Deprivation and Postoperative Mortality NCT07621211 · ClinicalTrials.gov ↗ · Social Deprivation	Observational	Recruiting	2026-05	Brazil
Diaphragmatic Ultrasonography in Difficult Weaning NCT07751237 · ClinicalTrials.gov ↗ · Weaning Mechanical Ventilation, ICU Ill Patients, Diaphragm Dysfunction	Not applicable	Recruiting	2026-08	Brazil
Taurine Effect on Glycemic, Lipidic and Inflammatory Profile in Individuals With Type 2 Diabetes NCT04874012 · ClinicalTrials.gov ↗ · Diabetes Mellitus, Type 2	Phase 2	Recruiting	2021-06	Brazil
Povidone-iodine vs Saline Solution in Colorectal Surgeries and Its Effects on the Surgical Site Infection NCT06302335 · ClinicalTrials.gov ↗ · Surgical Site Infection Drug: Povidone-iodine	Phase 3	Recruiting	2023-01	Brazil
Comparison of Paravertebral Versus Epidural Block for Post-thoracotomy Pain Control NCT07763249 · ClinicalTrials.gov ↗ · Postoperative Pain	Not applicable	Not yet open	2026-09	Brazil
EFFECT OF A PHYSICAL EXERCISE PROGRAM ON FUNCTIONAL CAPACITY AND FALL PREVENTION IN PSYCHIATRIC INPATIENT CARE NCT07827547 · ClinicalTrials.gov ↗ · Fall Risk	Not applicable	Not yet open	2026-10	Brazil
NK Cell Infusion for Remission Consolidation in AML: A Phase II Trial NCT06783478 · ClinicalTrials.gov ↗ · Acute Myeloid Leukaemia (AML)	Phase 2	Not yet open	2025-04	Brazil
IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency NCT06434025 · ClinicalTrials.gov ↗ · Heart Failure, Systolic, Iron Deficiencies Drugs: Dapagliflozin, Dapagliflozin Tab, Ferinject	Phase 3	Not yet open	2024-05	Brazil
Health Education for Women With Suspeced Infertility Waiting for Specialized Care NCT06979063 · ClinicalTrials.gov ↗ · Infertility, Health Education, Telemedicine	Not applicable	Not yet open	2025-06	Brazil
Navigation for Elderly People With Multiple Morbidity After Hospital Discharge. NCT07546006 · ClinicalTrials.gov ↗ · Multimorbidity	Not applicable	Not yet open	2026-06	Brazil
Frequency-Dependent Effects of Transcranial Photobiomodulation With Same Peak Irradiance on Cortical Excitability and Fine Motor Performance NCT07752602 · ClinicalTrials.gov ↗ · Healthy Volunteers (HV), Transcranial Photobiomodulation, Cortical Excitability	Phase 1	Not yet open	2027-01	Brazil
High-Protein Diet and HMB Supplementation in Patients With Heart Failure NCT07731048 · ClinicalTrials.gov ↗ · Heart Failure	Not applicable	Not yet open	2026-09	Brazil
Impact of Pharmacist-led Care Navigation Mediated by Digital Health Tools on Hospital Readmissions NCT07789353 · ClinicalTrials.gov ↗ · Ambulatory Care Sensitive Conditions	Not applicable	Not yet open	2026-08	Brazil
Frequency-Dependent Effects of Transcranial Photobiomodulation on Cortical Excitability NCT07707284 · ClinicalTrials.gov ↗ · Healthy Volunteers (HV), Transcranial Photobiomodulation, Cortical Excitability	Phase 1	Not yet open	2027-05	Brazil
General Versus Regional Anesthesia in Peripheral Arterial Surgery NCT06953128 · ClinicalTrials.gov ↗ · Postoperative Complications, Cardiovascular Diseases	Not applicable	Not yet open	2025-07	Brazil
POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure NCT07469722 · ClinicalTrials.gov ↗ · Acute Heart Failure (AHF), Congestive Heart Failure Acute, Diuretic Effect Drugs: Dapagliflozin, Hydrochlorothiazide (HCTZ) 25 milligrams	Phase 2/3	Not yet open	2026-03	Brazil
Triple-Blind Randomized Clinical Trial of Tocilizumab vs Placebo: Potential Use of an IL-6 Antagonist as an Adjuvant to Standard Treatment for Treatment-Resistant Major Depression in the Brazilian Public Health System (SUS) NCT07052058 · ClinicalTrials.gov ↗ · Treatment-Resistant Major Depressive Disorder Drug: Tocilizumab	Phase 2	Not yet open	2026-07	Brazil
Effects of Tummy Time Associated With Therapeutic Positioning in Premature Newborns With Cranial Asymmetry NCT07758426 · ClinicalTrials.gov ↗ · Premature Newborns, Cranial Asymmetry	Not applicable	Not yet open	2026-10	Brazil
Use Of A Tongue Strength Training Device And Its Relationship With Speech In Patients With Parkinson's Disease NCT06921122 · ClinicalTrials.gov ↗ · Parkinson Disease (PD)	Not applicable	Not yet open	2025-04	Brazil
Meal Frequency and Glycemic Control in Individuals With Type 1 Diabetes NCT06934707 · ClinicalTrials.gov ↗ · Type 1 Diabetes (T1D), Nutrition Therapy, Glycemic Control for Diabetes Mellitus	Not applicable	Not yet open	2025-04	Brazil
Bleeding Prevention With Desmopressin for Allograft Kidney Biopsies NCT06622187 · ClinicalTrials.gov ↗ · Bleeding, Transplant, Kidney, Desmopressin Drugs: Ddavp, Desmopressin	Phase 4	By invitation	2024-08	Brazil
Effect of Different Currents for Transcranial Modulation of the Sensorimotor Corticospinal Pathway in Healthy Subjects NCT07831525 · ClinicalTrials.gov ↗ · Health Adult Subjects	Not applicable	By invitation	2026-07	Brazil
Effects of Light Exposure for Postpartum Depression on Infant Development NCT07440355 · ClinicalTrials.gov ↗ · Development and Health, Nutrition	Observational	By invitation	2024-08	Brazil
Continuous Renal Replacement Therapy Intensity in Hyperammonemia NCT06987604 · ClinicalTrials.gov ↗ · Acute Liver Failure, Acute on Chronic Liver Failure (ACLF), Acute Kidney Injury	Not applicable	By invitation	2025-03	Brazil
12-Week Strength and Functional Exercise Program for Hereditary Spastic Paraplegia Trial (HSPMOVE) NCT07561359 · ClinicalTrials.gov ↗ · Hereditary Spastic Paraplegia	Not applicable	By invitation	2024-04	Brazil
Primary Care Transfer for Thyroid Cancer Patients NCT03794375 · ClinicalTrials.gov ↗ · Differentiated Thyroid Cancer	Not applicable	Active, closed	2019-01	Brazil
Cortical Excitability Modulation With ctDCS in Fibromyalgia. NCT05963321 · ClinicalTrials.gov ↗ · Fibromyalgia, Chronic Pain	Not applicable	Active, closed	2023-06	Brazil
Evaluation of Serological Markers of Vitiligo Activity NCT06731283 · ClinicalTrials.gov ↗ · Vitiligo	Observational	Active, closed	2023-04	Brazil

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Drugs in Hospital de Clinicas de Porto Alegre trials

15 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

Dapagliflozin2 Cefuroxime1 Dapagliflozin Tab1 Ddavp1 Desmopressin1 Duloxetine1 Ferinject1 Hydrochlorothiazide (HCTZ) 25 milligrams1 Letrozole1 Methotrexate1 Methotrexate Sodium1 Methylphenidate1 Povidone-iodine1 Tacrolimus1 Tocilizumab1

Conditions in Hospital de Clinicas de Porto Alegre trials

87 conditions

Heart Failure2Healthy Volunteers (HV)2Transcranial Photobiomodulation2Cortical Excitability2Diabetes Mellitus, Type 22Oral Erosive Lichen Planus1Differentiated Thyroid Cancer1Postoperative Pain1Bleeding1Transplant, Kidney1Desmopressin1Kidney Biopsy1Fall Risk1Acute Myeloid Leukaemia (AML)1Health Adult Subjects1Heart Failure, Systolic1Iron Deficiencies1Fibromyalgia1 Chronic Pain1 Infertility1Health Education1Telemedicine1Telehealth1Pulmonary Hypertension1

By trial register

Register	Trials	Recruiting
Clinical trials in Brazil	50	26

A trial with sites in more than one country appears in each of those registers.

Other sponsors in Heart Failure

Sponsor	Trials
Jiangsu Taizhou People's Hospital	7
Edwards Lifesciences	5
Impulse Dynamics	5
University Medical Center Groningen	5
XVIVO Perfusion	4
Yonsei University	4
Population Health Research Institute	3
Medtronic	3
Foundry Innovation & Research 1, Limited (FIRE1)	3
Abiomed	3

Sponsors with the most current trials registered for this condition.

Questions about Hospital de Clinicas de Porto Alegre trials

How many clinical trials does Hospital de Clinicas de Porto Alegre sponsor?

Hospital de Clinicas de Porto Alegre is the lead sponsor of 50 current trials on ClinicalTrials.gov in our Brazil register, as of the registry sync on 14 November 2026. Completed and withdrawn studies are not counted.

Are Hospital de Clinicas de Porto Alegre trials recruiting?

Yes. 26 of its 50 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Hospital de Clinicas de Porto Alegre testing?

Its current trials name 15 drugs and biologicals as interventions. The most frequent are Dapagliflozin (2), Cefuroxime (1), Dapagliflozin Tab (1), Ddavp (1) and Desmopressin (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 14 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.